HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 05-26-2006, 03:59 PM   #1
Christine MH-UK
Senior Member
 
Join Date: Sep 2005
Posts: 414
Use may not be what you expect

Hi RB,

Yes, it is unfortunate that more money isn't put into the non-profitable research. However, did you know that there was a small trial done that showed that fish oil decreased weight loss in terminally ill patients?

Anyway, the drugs companies may use this type of information in ways they find profitable. There is actually a drug in development called DHA-paclitaxel or taxoprexin that attaches DHA to taxol. Cancers disproportionately suck in fatty acids, so the DHA gets more of the drug into cancer cells. Once the cancer cell takes in the DHA, it breaks off from the taxol, activating the drug and simultaneously, in theory, chemosensitizing the cancer cell. I think that it is being tried out in metastatic melanoma first:
http://www.scienceblog.com/community...200002582.html for the phase I trial results. The interesting thing is there were fewer side effects.

"The researchers reported that, at the highest dose of Taxoprexin® DHA-paclitaxel, they were able to administer 4.6 times more taxane than the maximum approved clinical dose of Taxol®. Some patients experienced a temporary reduction in their white blood cells. However, the reductions were transient and cell numbers returned to normal without treatment. None of the patients experienced hair loss or nerve problems, which are toxic side effects frequently associated with Taxol® and Taxotere®. In addition, no nausea or vomiting toxicities were seen."

So, this information does get used, but perhaps not in the less profitable ways.
Christine MH-UK is offline   Reply With Quote
Old 05-26-2006, 04:12 PM   #2
R.B.
Senior Member
 
Join Date: Mar 2006
Posts: 1,843
Re Omega threes fish oil in liquid intravenous feeds - Yes I have seen a few mentions in various trials suggesting benifit of upping threes in intravenous feed to various conditions.

Re using fat hunger of tumours as targeting sensor - No I dont think I have seen for Taxol but they appear to be trying for a number of agents.

But the key question is are they not simply looking for solutions to a problem that in large part could be simply resolved by resolving the optimal fat intake proportions - and if that is the case how do they in the board room justify the suffering it is putting women and children through.


Thanks for the response

RB
R.B. is offline   Reply With Quote
Old 05-26-2006, 07:56 PM   #3
Lolly
Senior Member
 
Lolly's Avatar
 
Join Date: Aug 2001
Location: Oregon
Posts: 1,756
I think the truth is most of the board room decisions are made in the cold light of financial gain, no human toll considered. I believe the scientists and doctors are for the most part working for the common good, but the corporate good is an entirely different kettle of fish.

<3 Lolly
Lolly is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:36 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter